Cargando…
Premedications for Cancer Therapies: A Primer for the Hematology/Oncology Provider
Chemotherapeutic agents and radiation therapy are associated with numerous potential adverse events (AEs). Many of these common AEs, namely chemotherapy- or radiation-induced nausea and vomiting, hypersensitivity reactions, and edema, can lead to deleterious outcomes (such as treatment nonadherence...
Autores principales: | Clemmons, Amber, Gandhi, Arpita, Clarke, Andrea, Jimenez, Sarah, Le, Thuy, Ajebo, Germame |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631343/ https://www.ncbi.nlm.nih.gov/pubmed/35295545 http://dx.doi.org/10.6004/jadpro.2021.12.8.4 |
Ejemplares similares
-
Lenalidomide-Associated Immune Thrombocytopenia: A Case Report and Review of the Literature
por: Forehand III, William, et al.
Publicado: (2020) -
Epidemiology, Staging, and Management of Multiple Myeloma
por: Padala, Sandeep Anand, et al.
Publicado: (2021) -
Premedication in Anæsthesia
por: Anderson, Olive
Publicado: (1944) -
Systemic toxicities of trastuzumab‐emtansine predict tumor response in HER2+ metastatic breast cancer
por: Tang, Shou‐Ching, et al.
Publicado: (2021) -
Does premedication with dexmedetomidine provide perioperative hemodynamic stability in hypertensive patients?
por: Sezen, Gulbin, et al.
Publicado: (2014)